Skip to main content

HIV Prevention 2.0 (HP2)

Using molecular, statistical and economic evaluation to describe the benefit of integrated stigma mitigation interventions (ISMI) to potentiate the effectiveness of existing HIV prevention, treatment, and care services for key populations including men who have sex with men and female workers in Senegal

Project Dates: September 2013 – September 2016

Principal Investigator: Stefan Baral

Co-Investigators: Fatou Drame; Carmen Logie; David Dowdy; Daouda Diouf,

Description: HP2 is an implementation science award with three specific aims: 1. Systematically review the literature for existing stigma metrics that have been used for MSM and FSW; 2. Characterize the current state of knowledge of the continuum of HIV care for men who have sex with men (MSM) and female sex workers (FSW) in Sub-Saharan Africa (SSA) using systematic reviews and secondary data analysis; and 3. Use a prospective cohort of MSM and FSW in Senegal followed for 24 months to evaluate non-randomized Integrated Stigma Mitigation Interventions (ISMI) including peer, clinic, and web-based components. The study will measure impacts of a scalable package of ISMI for key populations in Dakar, Thies, and Mbour, Senegal. The outcomes will include coverage of HIV and health services and, for participants living with HIV, adherence to antiviral therapy (ART) and viral load (VL) measures.

Collaborative Partners: Enda-Santé and Gaston-Berger University

Funding Source: United States Agency for International Development (USAID)